Modified Tapioca Starch Bilayer Tablets for Dual Release Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral compositions using native tapioca starch do not provide suitable controlled-release of active agents, and formulations with hydrophilic polymers often fail to maintain desired release profiles in higher pH environments, particularly in the intestines, and include undesirable synthetic components.
Innovation Solution
A multilayer formulation comprising a first layer with modified tapioca starch for controlled-release and a second layer for immediate-release, allowing for tailored release profiles in the gastrointestinal tract, using a bilayer or trilayer tablet design with specific active agents and excipients to achieve controlled and immediate release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If native tapioca starch is used as a diluent and binder in tablet formulations, then the formulation is simple and cost-effective, but it does not provide suitable controlled-release of active agents
Solution Approach 1:
The patent applies parameter changes by modifying the physical and chemical properties of tapioca starch through crosslinking with agents such as borax, boric acid, or other crosslinking agents. This modification transforms the starch from a rapidly disintegrating native form into a controlled-release formulation that maintains structural integrity in the gastrointestinal tract, thereby achieving both manufacturing simplicity and extended release performance.
Solution Approach 2:
The patent creates a composite material by combining tapioca starch with crosslinking agents and other formulation components to form a multilayer tablet structure. The crosslinked starch forms a hydrophilic matrix that controls drug release, while the composite structure integrates multiple functional layers for immediate and controlled release, resolving the contradiction between simplicity and controlled-release performance.
2Duration of action of moving object
If hydrophilic polymers are used to achieve controlled-release, then the release profile is improved, but the formulation fails to maintain desired release profiles in higher pH environments and includes undesirable synthetic components
Solution Approach 1:
The patent employs parameter changes by utilizing starch that is modified through crosslinking, which alters its pH-responsive behavior. The crosslinked starch structure maintains its gel-forming capability and controlled-release properties in higher pH environments like the intestine, overcoming the limitation of conventional hydrophilic polymers that dissolve in alkaline conditions. This natural polymer modification eliminates synthetic polymers while maintaining release profile consistency.
Solution Approach 2:
The patent replaces expensive and synthetic hydrophilic polymers with a natural, biodegradable alternative—crosslinked tapioca starch. This natural polymer is cost-effective, free from synthetic additives, and provides the same controlled-release function through its hydrophilic matrix formation, thereby eliminating the need for undesirable synthetic components while maintaining reliability.
3Device complexity
If a single-layer formulation is used, then the device complexity is low, but it cannot provide both immediate and controlled release profiles simultaneously
Solution Approach 1:
The patent applies segmentation by dividing the tablet into multiple functional layers: an outer immediate-release layer containing rapidly disintegrating starch or other immediate-release excipients, and an inner controlled-release layer containing crosslinked starch with active agents. This segmentation allows each layer to perform its specific release function independently, providing both immediate and controlled release profiles in a single formulation without excessive complexity.
Solution Approach 2:
The patent utilizes the spatial dimension by creating a multilayer tablet structure where different layers are positioned at different locations within the tablet. The immediate-release layer is positioned for rapid dissolution upon contact with gastrointestinal fluids, while the controlled-release layer is positioned to provide sustained release. This dimensional arrangement enables dual release profiles without requiring multiple separate formulations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multilayer formulation ensures controlled release of active agents over an extended period, with immediate release at specific sites in the GI tract, improving compliance and absorption, while avoiding synthetic polymers and maintaining desired serum concentrations.
Implementation Method 1
The hydrophilic matrix swells upon contact with water, thereby creating a protective gel layer from which the active agents are slowly, gradually, or continuously released
Implementation Method 2
forming a gel when exposed to an aqueous environment of low pH thereby slowly diffusing the active medicament which is contained within the polymer matrix
Implementation Method 3
the active agents are slowly, gradually, or continuously released in time either by diffusion through the polymeric network, by erosion of the gel layer, by dissolution of the polymer
Implementation Method 4
the active agents are slowly, gradually, or continuously released in time either by diffusion through the polymeric network, by erosion of the gel layer, by dissolution of the polymer
Implementation Method 5
the active agents are slowly, gradually, or continuously released in time either by diffusion through the polymeric network, by erosion of the gel layer, by dissolution of the polymer
Data Source
AI summary
Provided is a multilayer formulation. The multilayer formulation is useful for controlled-release and immediate-release of active agents after administration to a subject. The multilayer formulation comprises a first layer comprising a controlled-release composition, and a second layer disposed adjacent the first layer and comprising an immediate-release composition. The controlled-release composition of the first layer comprises a first active agent and a controlled-release excipient comprising a modified tapioca starch. The modified tapioca starch provides for controlled-release of the first active agent from the first layer. The immediate-release composition of the second layer comprises a second active agent and an excipient. The multilayer formulation can be in the form of a tablet, such as a bilayer tablet. The multilayer formulation may be administered orally to a subject to provide various types of active agents (e.g., vitamins, minerals, botanicals, etc.) at different locations of the subject's gastrointestinal (GI) tract.